Cite
MLA Citation
Shengli He et al.. “A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin.” Journal of chemotherapy, vol. 26, n.d., pp. 243–247. http://access.bl.uk/ark:/81055/vdc_100052536922.0x00003c